Ola Vedin
Overview
Explore the profile of Ola Vedin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fitchett D, Zinman B, Inzucchi S, Wanner C, Anker S, Pocock S, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):248.
PMID: 38992713
Background: The effect of empagliflozin, a sodium-glucose-co-transporter-2 inhibitor, on risk for myocardial infarction has not been fully characterized. Methods: This study comprised prespecified and post-hoc analyses of the EMPA-REG OUTCOME...
2.
Khan M, Anker S, Filippatos G, Ferreira J, Pocock S, Januzzi J, et al.
J Card Fail
. 2023 Aug;
29(10):1345-1354.
PMID: 37558088
Background: The presence of ischemic heart disease impacts prognosis in patients affected by heart failure and reduced ejection fraction (HFrEF). It is not well known how the extent of vascular...
3.
Randell R, Hornik C, Curtis L, Hernandez A, Denwood T, Nebeker C, et al.
Contemp Clin Trials
. 2023 Jul;
132:107304.
PMID: 37481202
Background: Digitization (using novel digital tools and strategies) and consumerism (taking a consumer-oriented approach) are increasingly commonplace in clinical trials, but the implications of these changes are not well described....
4.
Narayanasamy S, Curtis L, Hernandez A, Woods C, Moody M, Sulkowski M, et al.
Clin Infect Dis
. 2023 Jul;
77(12):1635-1643.
PMID: 37435958
While the coronavirus disease 2019 (COVID-19) pandemic continues to present global challenges, sufficient time has passed to reflect on lessons learned and use those insights to inform policy and approaches...
5.
Siddiqi T, Anker S, Filippatos G, Ferreira J, Pocock S, Bohm M, et al.
Eur J Heart Fail
. 2023 Mar;
25(9):1623-1631.
PMID: 36974746
Aims: There are limited data on health status and changes in it over time across major subgroups of patients with heart failure and preserved ejection fraction (HFpEF), including ejection fraction...
6.
Khan M, Butler J, Anker S, Filippatos G, Ferreira J, Pocock S, et al.
J Am Heart Assoc
. 2022 Dec;
12(1):e027652.
PMID: 36565199
Background Outcomes and treatment effects of therapy may vary according to the cause of heart failure (HF). Methods and Results In this post hoc analysis of the EMPEROR-Reduced (Empagliflozin Outcome...
7.
Desai R, Glynn R, Everett B, Schneeweiss S, Wexler D, Bessette L, et al.
Am Heart J
. 2022 Sep;
254:203-215.
PMID: 36150454
Background: The effect of sodium glucose cotransporter 2 inhibitors (SGLT2i) on the total (first and recurrent) burden of cardiovascular (CV) hospitalizations, including hospitalization for heart failure, myocardial infarction, and stroke,...
8.
Wedin J, Vedin O, Rodin S, Simonson O, Horsne Malmborg J, Pallin J, et al.
Circulation
. 2022 Aug;
146(17):1310-1322.
PMID: 35971843
Background: Differences in adverse cardiac remodeling between patients who have bicuspid (BAV) and tricuspid aortic valve (TAV) with severe isolated aortic stenosis (AS) and its prognostic impact after surgical aortic...
9.
Januzzi Jr J, Butler J, Zannad F, Filippatos G, Ferreira J, Pocock S, et al.
JACC Heart Fail
. 2022 Jun;
10(7):512-524.
PMID: 35670067
Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) are associated with disease severity and outcomes among patients with heart failure (HF) with preserved ejection fraction. Objectives:...
10.
Harrington J, Jones W, Udell J, Hannan K, Bhatt D, Anker S, et al.
JACC Heart Fail
. 2022 Jun;
10(6):404-414.
PMID: 35654525
Acute coronary syndrome (ACS) is frequently complicated by evidence of heart failure (HF). Those at highest risk for acute decompensated HF in the setting of ACS (ACS-HF) are older, female,...